T2AA, Proliferating cell nuclear antigen (PCNA) inhibitor
Be the first to review this product! Submit a review
|
(2 Publications)
MW 511.09 Da, Purity >98%. Proliferating cell nuclear antigen (PCNA) inhibitor; inhibits PCNA/PIP-box peptide interaction (IC50 = ~1 μM). Inhibits PCNA interaction with DNA polymerase δ and arrests cell growth in S-phase. Causes DNA replication stress by stalling DNA replication forks. Suppresses cancer cell growth. T3 derivative that exhibits almost no thyroid hormone activity.
View Alternative Names
ATLD2, Cyclin, DNA polymerase delta auxiliary protein, HGCN8729, MGC8367, Mutagen-sensitive 209 protein, OTTHUMP00000030189, OTTHUMP00000030190, PCNAR, PCNA_HUMAN, Pcna/cyclin, Polymerase delta accessory protein, Proliferating cell nuclear antigen, cb16, etID36690.10, fa28e03, fb36g03, wu:fa28e03, wu:fb36g03
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein serves a core function in cell cycle regulation and DNA repair. PCNA acts as a scaffold for the assembly of numerous proteins involved in DNA processing forming part of the replication fork complex. It interacts with cyclins and cyclin-dependent kinases (CDKs) linking DNA synthesis to cell cycle progression. Furthermore PCNA partners with proteins involved in DNA mismatch repair base excision repair and nucleotide excision repair.
Pathways
PCNA is integral in the DNA replication and repair pathways. It closely associates with the p21 protein which regulates the cell cycle by inhibiting cyclin-CDK complexes upon DNA damage. PCNA also plays a part in the ubiquitin-proteasome pathway where its modification by ubiquitin impacts how cells respond to DNA damage. This modification recruits specific proteins for DNA repair highlighting its central role in maintaining genomic stability.
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
PLoS pathogens 19:e1011539 PubMed37486931
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 43:1805-1818 PubMed32236603
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com